These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 197175)

  • 1. Lymphocytosis-promoting factor of Bordetella pertussis: isolation, characterization, and biological activity.
    Morse SI
    J Infect Dis; 1977 Aug; 136 Suppl():S234-8. PubMed ID: 197175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
    Morse SI; Morse JH
    J Exp Med; 1976 Jun; 143(6):1483-502. PubMed ID: 58054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis.
    Arai H; Sato Y
    Biochim Biophys Acta; 1976 Oct; 444(3):765-82. PubMed ID: 186106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. I. Proliferative response.
    Kong AS; Morse SI
    J Exp Med; 1977 Jan; 145(1):151-62. PubMed ID: 187715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes: II. Nature of the responding cells.
    Kong AS; Morse SI
    J Exp Med; 1977 Jan; 145(1):163-74. PubMed ID: 187716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis.
    Meade BD; Kind PD; Manclark CR
    Dev Biol Stand; 1985; 61():63-74. PubMed ID: 2872133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of lymphoid and nonlymphoid cells with the lymphocytosis-promoting factor of Bordetella pertussis.
    Adler A; Morse SI
    Infect Immun; 1973 Mar; 7(3):461-7. PubMed ID: 4351588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human lymphocytes.
    Morse JH; Kong AS; Lindenbaum J; Morse SI
    J Clin Invest; 1977 Sep; 60(3):683-92. PubMed ID: 197121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Bordetella pertussis leukocytosis (lymphocytosis)-promoting factor (LPF) on the physical lymphoepithelial-cell association studied with the use of an in vitro model of mouse thymus.
    Sugimoto M; Nakanishi Y; Otokawa M; Uchida N; Yasuda T; Sato H; Sato Y
    J Immunol; 1983 Jun; 130(6):2767-74. PubMed ID: 6682875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation.
    Meade BD; Kind PD; Manclark CR
    Infect Immun; 1984 Dec; 46(3):733-9. PubMed ID: 6094357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes. IV. Generation, characterization, and specificity of cytotoxic lymphocytes.
    Kong AS; Morse SI
    J Exp Med; 1979 Jun; 149(6):1393-406. PubMed ID: 221613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells.
    Kashiwa H; Hyodo S; Kishi T; Karakawa T; Kittaka E; Suzawa T; Sakano T; Usui T
    Clin Exp Immunol; 1984 Nov; 58(2):436-43. PubMed ID: 6094059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed type hypersensitivity induced by LPF from Bordetella pertussis.
    Guadalupe Cortés JM; Juliano Y; Mendes NF; Mendes E
    Allergol Immunopathol (Madr); 1986; 14(4):311-7. PubMed ID: 2877558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1974 May; 9(5):801-10. PubMed ID: 4363229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1973 Jun; 7(6):992-9. PubMed ID: 4351972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenyl cyclase in Bordetella pertussis vaccines.
    Hewlett EL; Manclark CR; Wolff J
    J Infect Dis; 1977 Aug; 136 Suppl():S216-9. PubMed ID: 19542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A protein activator for the adenylate cyclase of Bordetella pertussis.
    Hewlett EL; Underhill LH; Cook GH; Manclark CR; Wolff J
    J Biol Chem; 1979 Jul; 254(13):5602-5. PubMed ID: 221475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.
    Meade BD; Kind PD; Ewell JB; McGrath PP; Manclark CR
    Infect Immun; 1984 Sep; 45(3):718-25. PubMed ID: 6088394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytosis and histamine sensitization of mice by fractions from Bordetella pertussis.
    Clausen C; Munoz J; Bergman RK
    J Bacteriol; 1968 Nov; 96(5):1484-7. PubMed ID: 4302297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.